$5.1 Billion Neuroscience Antibodies and Assays Market - Global Trajectory & Analytics 2012-2019 & 2020-2027 - ResearchAndMarkets.com

The "Neuroscience Antibodies and Assays - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Neuroscience Antibodies and Assays Market to Reach $5.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Neuroscience Antibodies and Assays estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at a CAGR of 8.8% over the period 2020-2027.

Consumables, one of the segments analyzed in the report, is projected to record 9.2% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.

The U. S. Market is Estimated at $831.1 Million, While China is Forecast to Grow at 8.2% CAGR

The Neuroscience Antibodies and Assays market in the U. S. is estimated at US$831.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$879.3 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• Abcam PLC
• BioLegend, Inc.
• Bio-Rad Laboratories, Inc.
• Cell Signaling Technology, Inc.
• F. Hoffmann-La Roche AG
• GenScript Biotech Corporation
• Merck KgaA
• Rockland Immunochemicals, Inc.
• Santa Cruz Biotechnology, Inc.
• Siemens Healthineers
• Tecan Group Ltd.
• Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Neuroscience Antibodies and Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

• Market Facts & Figures
• Neuroscience Antibodies and Assays Market Share (in %) by Company: 2019 & 2025
• Market Analytics
• Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Product: 2020 to 2027
• Neuroscience Antibodies and Assays Market by Product: A Historic Review in US$ Million for 2012-2019
• Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
• Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2020-2027
• Neuroscience Antibodies and Assays Market Retrospective Analysis in US$ Million by Technology: 2012-2019
• Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
• Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
• Neuroscience Antibodies and Assays Historic Demand Patterns by End-Use in US$ Million for 2012-2019
• Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

• Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/jsd7pi

View source version on businesswire.com: https://www.businesswire.com/news/home/20201002005237/en/